The relationship between hospital market consolidation and the price of hospital services is one of the most thoroughly studied questions in health economics. The answer the literature has produced, across decades of research, multiple methodologies, and hundreds of individual transactions, is consistent: consolidation raises prices. Not sometimes. Not in some markets. Consistently, across market types, ownership structures, and transaction forms.
This article examines the price evidence by mechanism — what horizontal merger produces, what vertical integration adds, what private equity acquisition contributes — and then draws the synthesis those components support. The conclusion is not that consolidation occasionally produces higher prices as an unintended side effect of transactions undertaken for other reasons. It is that the price effect is the primary financial logic of consolidation, and the evidence documents it as such.
What horizontal merger does to prices
The foundational research on hospital merger price effects was developed by economists Martin Gaynor and Robert Town, whose body of work over two decades established the methodological standard for the field. Their findings, replicated and extended by subsequent researchers, document a consistent pattern: hospitals that merge with nearby competitors raise prices faster than hospitals that do not. The magnitude varies by market — mergers that produce near-monopoly conditions in a local market produce larger price effects than mergers that reduce competition from four systems to three — but the direction does not vary.
The Cooper et al. research extended the analysis to cross-market mergers — acquisitions between hospital systems in different geographic markets that nonetheless produce price effects by strengthening the acquiring system’s bargaining position with insurers who operate across those markets. The mechanism is leverage at the negotiating table: a system that can credibly threaten to withdraw from an insurer’s network across multiple markets simultaneously has more leverage than one whose footprint is confined to a single market. The price effects of cross-market consolidation are smaller than same-market mergers but documented and material.
The mechanism in both cases is the same one identified in the horizontal merger article: must-have status. When a health system controls enough of a market’s hospital capacity that an insurer cannot exclude it and still offer a viable product, the negotiation that follows produces higher contracted rates. The research quantifies what that leverage is worth. Gaynor and Town’s work and subsequent studies estimate that hospital mergers resulting in near-monopoly market conditions produce price increases in the range of 20 to 40 percent above what prices would have been without the merger. In markets where consolidation has proceeded furthest, prices for hospital services are substantially higher than in markets that have retained more competitive structure.
What vertical integration adds
The price consequences of vertical integration operate through a different mechanism but compound the horizontal merger effect rather than replacing it.
The facility fee is the most direct expression. When a hospital system acquires an independent physician practice and converts it to a hospital outpatient department, it gains the ability to bill a facility fee — a charge for the use of the hospital’s facilities — on top of the professional fee for the physician’s service. The patient receives the same service, from the same physician, in the same office. The bill is larger. MedPAC, the independent advisory body that analyzes Medicare payment policy for Congress, has documented that Medicare pays hospital outpatient department rates that are on average 80 to 90 percent higher than the rates it pays for identical services delivered in a physician office setting. Commercial insurers, negotiating with systems that control their market, pay higher differentials still.
The referral capture dynamic documented in the vertical integration article has its own price consequence. When a system employs the primary care physicians who control patient referral streams, it directs those referrals to system-owned specialists, imaging facilities, and surgical centers. Independent providers — who might offer lower prices if patients could reach them — are structurally bypassed. The patient’s effective choice set narrows to system-owned options priced at system-contracted rates, regardless of whether lower-cost alternatives exist in the market.
Research examining the price effects of physician practice acquisition consistently finds significant price increases following acquisition — in the range of 14 to 26 percent for primary care acquisitions in studies published in the American Economic Review and the Journal of Health Economics. The same studies find no corresponding improvement in quality metrics that would account for the higher cost. The price increase follows the ownership transfer; the quality improvement does not.
What private equity contributes
Private equity acquisition adds a third price vector. The debt loading that characterizes PE acquisition creates cash flow pressure that manifests as higher prices where the acquired entity has the market position to extract them. PE-backed physician staffing firms — operating emergency medicine and anesthesiology practices at hospitals where they are the exclusive provider — have documented the most direct expression of this pressure: billing at out-of-network rates to patients who had no choice of provider. The No Surprises Act addressed that specific billing practice without addressing the ownership structure that generated it.
More broadly, PE-owned hospitals and practices in markets with sufficient consolidation to support it have shown price trajectories consistent with the horizontal and vertical consolidation literature. The investment horizon creates pressure toward margin expansion — through price increases where market position permits and cost reduction where it does not — that operates independently of and in addition to the market power effects of horizontal and vertical consolidation.
The synthesis: what the evidence means
Taken together, the price evidence from all three consolidation mechanisms documents something more than a series of individual market outcomes. It documents a structural relationship between hospital market concentration and the price of hospital services that operates consistently enough to function as a predictive model.
Markets with high consolidation have higher hospital prices. The research is consistent on this across time periods, geographic regions, and ownership types. The price effects compound as consolidation deepens — a market moving from four independent systems to two does not experience twice the price effect of a market moving from two to one; it experiences a larger effect because the leverage available to a near-duopoly is qualitatively different from the leverage available to one of four competitors.
The implication the evidence supports is direct: the price of hospital services in American healthcare is not primarily a function of the cost of delivering care. It is primarily a function of the market power that consolidated systems have acquired and the leverage that market power produces in negotiations with insurers. The hospital that charges $15,000 for a procedure that a hospital in a more competitive market charges $8,000 for is not delivering more expensive care. It is extracting a price its market position makes possible.
This matters for how the policy debate about hospital prices is framed. Arguments that hospital prices reflect the cost of uncompensated care, teaching mission, capital investment, or clinical complexity are partial at best. The research that controls for those factors finds the market power effect persists. Consolidation is not one factor among many in the price story. It is the primary structural driver of the gap between what Americans pay for hospital services and what comparable care costs in more competitive or more regulated markets.
What consolidation does to quality and staffing — the other dimension of the consequences the evidence documents — is examined in the article that follows.
All Hospital Consolidation Articles
00 — Hospital Consolidation Hub
01 — How Hospital Consolidation Works — and What It Produces
02 — Horizontal Merger: When Hospitals Buy Hospitals
03 — Vertical Integration: When Systems Acquire Everything
04 — Private Equity in Healthcare: What Happens When Hospitals Become Assets
05 — How Consolidation Drives Up Prices
06 — What Consolidation Does to Quality and Staffing
07 — How Consolidated Systems Squeeze Independent Physicians
08 — Rural Hospital Closures and the Consolidation Connection
09 — Why Antitrust Enforcement Failed the Hospital Market
10 — What Would Change It: Consolidation, Competition, and the Reform Debate
11 — What Single-Payer Resolves — and What It Doesn’t: The Evidence From This Hub
12 — Join the conversation in the Health Care Forum
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.